View Vessel Due – F mechanism of action for pharmacodynamics and pharmacokinetics details. MIMS Class Anticoagulants, Antiplatelets & Fibrinolytics (Thrombolytics), Vessel Due F (sulodexide): Vascular pathologies w/ thrombotic risk. 1 amp daily IM or IV for 15-20 days then, continue treatment w/ 1 cap bd for 30-40 days.
Object Moved This document may be found here, MIMS Class. Vitamins &/or Minerals. ATC Classification. A11JB – Vitamins with minerals : Used as dietary supplements. Vessel Due F . Vessel Due F cap 250 LSU. sulodexide. … Vessel Due F inj 600 LSU. sulodexide. Packing/Price. 10 × 1’s. MIMS Class. Anticoagulants, Antiplatelets & Fibrinolytics (Thrombolytics), MIMS Class. Anticoagulants, Antiplatelets & Fibrinolytics (Thrombolytics) … Vessel Due – F soln for inj 300 LSU/mL. sulodexide. Packing/Price (amp) 2 mL x 10 × 1’s. MIMS Class. Anticoagulants, Antiplatelets & Fibrinolytics (Thrombolytics) ATC Classification. B01AB11 – sulodexide : Belongs to the class of heparin group. Used in the treatment of …
Vessel Due F contains Sulodexide glycosaminglycan featuring a marked antithrombotic action either on arterial or venous systems. Several clinical studies based on parenteral and oral product’s administration show that the antithrombotic action of Sulodexide is due to the dose-dependent inhibition of some coagulative factors among which, first …
Vessel Due F is a medicine available in a number of countries worldwide. A list of US medications equivalent to Vessel Due F is available on the Drugs.com website.
The low molecular weight of both Vessel Due F fractions allows for extensive oral absorption compared to unfractionated heparin. The pharmacological effects of Vessel Due F differ substantially from other glycosaminoglycans and are mainly characterized by a prolonged half-life and reduced effect on global coagulation and bleeding parameters.
Disclaimer: This information is independently developed by MIMS based on Sulodexide from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to MIMS Product Monographs for specific and locally approved prescribing information.
Vessel Due F m?že zesilovat ú?inky heparinu a perorálních antikoagulancií. Ú?inek lé?by m?že být v n?kterých p?ípadech zvyšován sou?asným podáním lék? ovliv?ujících agregaci trombocyt? (kyselina acetylsalicylová, ibuprofen, fenylbutazon, indometacin, dipyridamol, dextran).
